Ivermectin Combined With Immune Checkpoint Inhibition in Cancer (ICONIC)

Clinical trial NCT07487805 · NOT_YET_RECRUITING

Trial details

NCT number: NCT07487805
Sponsor: University of Florida
Status: NOT_YET_RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Solid Tumor, Adult

Start date: 2026-09-01
Primary completion: 2027-09-01
Enrollment: 80

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.